Abstract
Both melengestrol acetate (MGA)1 and hydrocortisone acetate under our experimental conditions not only prevented the development of experimental allergic encephalomyelitis but also reversed the established disease. MGA was in general superior to hydrocortisone acetate in both prophylactic and therapeutic treatment and showed fewer side effects associated with glucocorticord activity. These observations were demonstrated both clinically and histologically.
Footnotes
- Received September 10, 1969.
- Accepted February 1, 1970.
- © 1970, by The Williams & Wilkins Company
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.